Literature DB >> 23277773

Ethics of ongoing cancer care for patients making risky decisions.

Jeffrey Peppercorn1.   

Abstract

Patients who decline conventional cancer therapy yet seek to continue follow-up while pursuing alternative therapy can pose an ethical challenge. The potential benefits and harms of an ongoing clinical relationship need be assessed on a case-by-case basis. Ongoing efforts at communicating, understanding the patient’s basis for decision making, and seeking to negotiate evidence-based care that is respectful of the patient’s preferences may improve outcomes.13 However, respect for the patient’s autonomy does not require support for inappropriate care and should not require that the oncologist check his or her professional judgment at the door.

Entities:  

Mesh:

Year:  2012        PMID: 23277773      PMCID: PMC3439236          DOI: 10.1200/JOP.2012.000622

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  12 in total

1.  Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).

Authors: 
Journal:  Harv Law Rev       Date:  2008-04

Review 2.  Salvage mastectomy.

Authors:  M P Osborne
Journal:  Semin Surg Oncol       Date:  1991 Sep-Oct

3.  Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

Authors:  Caroline Lohrisch; Charles Paltiel; Karen Gelmon; Caroline Speers; Suzanne Taylor; Jeff Barnett; Ivo A Olivotto
Journal:  J Clin Oncol       Date:  2006-10-02       Impact factor: 44.544

4.  Deciding life and death in the courtroom. From Quinlan to Cruzan, Glucksberg, and Vacco--a brief history and analysis of constitutional protection of the 'right to die'.

Authors:  L O Gostin
Journal:  JAMA       Date:  1997-11-12       Impact factor: 56.272

5.  American society of clinical oncology statement: toward individualized care for patients with advanced cancer.

Authors:  Jeffrey M Peppercorn; Thomas J Smith; Paul R Helft; David J Debono; Scott R Berry; Dana S Wollins; Daniel M Hayes; Jamie H Von Roenn; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

6.  Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients.

Authors:  Abigail M Gross; Qin Liu; Susan Bauer-Wu
Journal:  J Oncol Pract       Date:  2007-11       Impact factor: 3.840

7.  Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.

Authors:  Jeffrey Peppercorn; Iuliana Shapira; Deborah Collyar; Teresa Deshields; Nancy Lin; Ian Krop; Hans Grunwald; Paula Friedman; Ann H Partridge; Richard L Schilsky; Monica M Bertagnolli
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

Review 8.  Complementary and alternative medicine use among women with breast cancer.

Authors:  Lisa M DiGianni; Judy E Garber; Eric P Winer
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

9.  Refusal of care: the physician-patient relationship and decisionmaking capacity.

Authors:  Jeremy R Simon
Journal:  Ann Emerg Med       Date:  2007-06-20       Impact factor: 5.721

10.  American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.

Authors:  Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn
Journal:  J Clin Oncol       Date:  2012-02-06       Impact factor: 44.544

View more
  3 in total

1.  Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

Authors:  Laura Tenner; Fay J Hlubocky; Charles D Blanke; Thomas W LeBlanc; Jonathan M Marron; Molly M McGinnis; Rebecca A Spence; Lynne P Taylor
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Potential Unintended Consequences Of Recent Shared Decision Making Policy Initiatives.

Authors:  Jennifer Blumenthal-Barby; Douglas J Opel; Neal W Dickert; Daniel B Kramer; Brownsyne Tucker Edmonds; Keren Ladin; Monica E Peek; Jeff Peppercorn; Jon Tilburt
Journal:  Health Aff (Millwood)       Date:  2019-11       Impact factor: 6.301

3.  Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

Authors:  Chetana Lim; Philippe Compagnon; Mylène Sebagh; Chady Salloum; Julien Calderaro; Alain Luciani; Gérard Pascal; Alexis Laurent; Eric Levesque; Umberto Maggi; Cyrille Feray; Daniel Cherqui; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2015-05-16       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.